COMPOSER

by University of California San Diego School of Medicine  · Based in United States → — Revolutionizing Sepsis Treatment: UC San Diego Health's COMPOSER Model and the Future of AI in Medicine
Critical Care Emergency Medicine Infectious Disease

Contact for pricing

Overview

COMPOSER (COnformal Multidimensional Prediction Of SEpsis Risk) is a sophisticated deep learning artificial intelligence algorithm developed by UC San Diego School of Medicine. It is designed for the early prediction of sepsis in emergency and inpatient settings. The model continuously monitors over 150 patient variables, including vital signs, demographics, lab results, current medications, and medical history, to identify patterns indicative of sepsis onset before obvious clinical manifestations.

COMPOSER works silently and safely behind the scenes, surveilling every patient for signs of possible sepsis. When a patient presents with multiple variables indicating a high risk for sepsis, the AI algorithm notifies nursing staff via the hospital’s electronic health record (EHR). This early detection capability has led to a significant reduction in mortality and an increase in compliance with sepsis treatment protocols.

The model has been trained using data from approximately 500,000 patients at the Urgent Care Center and over 100,000 digital patient records from previous sepsis cases. Studies have shown that COMPOSER can detect sepsis roughly four to six hours before a clinician would be able to diagnose it, resulting in a 1.7% to 1.9% absolute reduction in in-hospital sepsis mortality, which translates to a 17% relative decrease. It also led to a 5% absolute increase in compliance with sepsis treatment bundles.

Ongoing improvements to the model include the incorporation of large language models (LLMs) to enhance data accuracy and reduce false alarms, leading to the development of COMPOSER-LLM, which significantly outperforms the standalone COMPOSER model.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Real-time sepsis prediction
  • Analyzes over 150 patient variables
  • Deep learning AI model
  • Notifies nursing staff via EHR
  • Reduces sepsis mortality by 17%
  • Increases sepsis treatment compliance by 5%
  • Detects sepsis 4-6 hours earlier than clinicians
  • Designed to reduce false alarms
  • Integration with Large Language Models (COMPOSER-LLM)
  • Continuously surveils patients

Use Cases

  • Early detection of sepsis in emergency departments
  • Early detection of sepsis in inpatient units
  • Improving patient outcomes in critical care settings
  • Enhancing compliance with sepsis treatment protocols
  • Supporting clinical reasoning at the point of care

Details

Category Clinical Decision Support & Reference, Triage & ER/ICU AI
Pricing Contact for pricing
DeploymentCloud-based (Amazon Web Services) and integrated into EHR systems
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status Unknown AI-estimated
Integrations
EHR Not specified
Specialties Critical Care, Emergency Medicine, Infectious Disease

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate COMPOSER

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

UC San Diego Health
Study: AI Surveillance Tool Successfully Helps to Predict Sepsis, Saves Lives
A new study published in npj Digital Medicine highlights the success of UC San Diego Health's COMPOSER AI algorithm in emergency departments, leading to a 17% reduction in sepsis mortality. The AI model continuously monitors over 150 patient variables to predict sepsis before obvious clinical manifestations, allowing for quicker life-saving therapy.
2024-01
npj Digital Medicine
Impact of a deep learning sepsis prediction model on quality of care and survival
This peer-reviewed study details a before-and-after quasi-experimental study at UC San Diego Health, demonstrating that the deployment of the COMPOSER deep-learning model for early sepsis prediction was associated with a significant 17% reduction in in-hospital sepsis mortality and a 10% increase in sepsis bundle compliance.
2024-01
The UCSD Guardian
Revolutionizing Sepsis Treatment: UC San Diego Health's COMPOSER Model and the Future of AI in Medicine
This article discusses UC San Diego's COMPOSER model, a sophisticated AI algorithm revolutionizing sepsis detection and treatment in emergency settings, which has led to a 17% relative decrease in mortality. Dr. Gabriel Wardi explains the model's development, which processes over 150 variables from patient data to predict sepsis onset.
2024-02
Healthcare Brew
How UC San Diego Health used AI to reduce its sepsis mortality rate
UC San Diego Health utilized its deep learning AI model, COMPOSER, to reduce its sepsis mortality rate by 17%. The model detects sepsis in patients 4-6 hours earlier than traditional methods by analyzing approximately 150 variables from electronic health records.
2024-04
PMC (Bioengineering)
Integrating artificial intelligence into healthcare systems: more than just the algorithm
This editorial discusses the successful implementation of COMPOSER within two UC San Diego Health emergency departments, which was associated with a 17% relative reduction in in-hospital mortality and a 10% increase in sepsis bundle compliance. It emphasizes the importance of evaluating clinically relevant outcomes for AI tools in healthcare.
2024-03
TechTarget
UC San Diego Risk Stratification AI Predicts Sepsis, Reduces Mortality
Researchers at UC San Diego School of Medicine found that their AI model, COMPOSER, deployed in emergency departments, significantly reduced sepsis mortality rates by 17%. The deep learning tool continuously monitors over 150 variables to identify sepsis risk early.
2024-01
Critical Care Medicine
Quantifying Healthcare Provider Perceptions of a Novel Deep Learning Algorithm to Predict Sepsis: Electronic Survey
This study evaluates healthcare worker perception and acceptance of COMPOSER, a deep learning algorithm for early sepsis prediction used at two UC San Diego Health emergency departments. The algorithm predicts sepsis before clear clinical presentation by using routinely collected patient data.
2025-06
PMC (Nature Medicine)
Development and Prospective Implementation of a Large Language Model based System for Early Sepsis Prediction
This article discusses the COMPOSER model, which was trained to predict sepsis onset up to four hours in advance and was associated with a 17% relative reduction in in-hospital sepsis mortality at UCSD Health. It also details the prospective deployment of the COMPOSER-LLM pipeline in two EDs within the UCSD Health system starting May 1, 2024.
2025-03

Videos

Product demos, reviews, and walkthroughs for COMPOSER.

View all on YouTube

Frequently Asked Questions

COMPOSER is a visual cohort analysis tool designed to help clinicians assess patient treatment options by analyzing prior cases with similar characteristics. It allows for dynamic definition of patient cohorts using demographic information, clinical parameters, and medical history, and then analyzes patient-reported outcome scores over time, comparing them across different cohorts. While initially developed for orthopedic research, it's believed to be generalizable to other healthcare domains and aims to become a shared decision-making tool.
While the provided information doesn't explicitly detail COMPOSER's internal compliance mechanisms, Clinical Decision Support (CDS) tools in general are designed to integrate evidence-based knowledge and guidelines into care delivery. Effective CDS systems aim to provide reliable and accurate alerts, incorporate patient medical history, and be tailored to the clinical context to enhance adherence to guidelines and improve patient safety.
The landscape of clinical decision support tools is diverse, with over 30 vendors offering various architectures and focus areas. Alternatives to COMPOSER could include expert-based systems that synthesize evidence into knowledge bases, analytics tools for real-time knowledge generation, and other CDS platforms that offer features like order sets, patient data summaries, documentation templates, and diagnostic support. Examples of other CDS tools mentioned in research include 'ePEPS,' 'CaVa,' 'CareFlow,' and 'Patient-like-mine.'
The provided information does not specify the pricing model for COMPOSER. However, for clinical decision support tools in general, demonstrating a return on investment (ROI) is a significant challenge for adoption. Implementations of CDS have been shown to improve guideline adherence, reduce medication errors, cut chart-review time, and often reach payback within 12-18 months.
While COMPOSER offers significant benefits, potential limitations in a busy clinical setting could include the time required for dynamic cohort definition and analysis, the need for seamless integration into existing workflows, and the potential for 'alert fatigue' if not implemented thoughtfully. General limitations of CDS tools can also include a lack of trust in the information presented in alerts and the need for alerts to be specific to the clinical context and patient under examination.
The provided information does not specifically detail COMPOSER's approach to patient data privacy and security. However, for any clinical decision support tool utilizing patient data, adherence to privacy regulations like HIPAA and robust security measures such as encrypted data flows and audit logging are critical considerations for hospital deployment.
The information suggests that COMPOSER utilizes electronic health record data for cohort definition and analysis. Generally, effective clinical decision support tools are designed to integrate with EHR systems to provide tailored, patient-specific information at the point of care, enhancing informed decision-making and improving communication across the care team.

Related Tools

DeepMind (Google)
Google DeepMind
Clinical Decision Support & Reference
AlphaFold is an AI system developed by DeepMind (Google) that accurately predicts protein structures and their interactions, significantly accelerating biological and medical research.
Tempus AI
Tempus AI
Clinical Decision Support & Reference
Tempus ECG-AI Platform uses artificial intelligence to analyze electrocardiogram data, offering advanced insights for cardiovascular diagnosis and management.
Cortex
Cortex
Clinical Decision Support & Reference
Cortex Workspace is a secure, HIPAA-compliant AI platform designed to streamline healthcare workflows and enhance decision-making for physicians.
SureMediks ProView
SureMediks (Rasimo Systems, LLC)
Clinical Decision Support & Reference
SureMediks is an AI-powered clinical decision support and metabolic health platform that automates care workflows for specialists, providing AI-generated patient summaries, automated chart review, and real-time biometric alerts.
SOAP Health
SOAP Health
Clinical Decision Support & Reference
SOAP Health is a Florida-based startup transforming patient intake with AI-powered diagnosis, offering a comprehensive solution that improves diagnosis accuracy and empowers patients and physicians.
Oxipit ChestLink
Oxipit (part of Sectra group)
Clinical Decision Support & Reference
Oxipit ChestLink is the world's first CE Class IIb-certified autonomous AI application for healthy chest X-ray reporting, capable of identifying normal studies with 99.9% sensitivity. It automates the reporting of normal chest X-rays, reducing radiologist workload and improving efficiency.

See all Clinical Decision Support & Reference tools →

Suggest an Edit → | Last Verified: 2026-06-19 | First Added: 2026-06-19
AI Tool Finder
AI-powered search. Results may not be comprehensive.